Daxor (DXR) Competitors $10.14 +0.14 (+1.40%) As of 07/25/2025 02:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR vs. SGHT, TLSI, INGN, PROF, KRMD, BSGM, LNSR, ELMD, PDEX, and PTHLShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), KORU Medical Systems (KRMD), Biosig Technologies (BSGM), LENSAR (LNSR), Electromed (ELMD), Pro-Dex (PDEX), and Pheton (PTHL). These companies are all part of the "medical equipment" industry. Daxor vs. Its Competitors Sight Sciences TriSalus Life Sciences Inogen Profound Medical KORU Medical Systems Biosig Technologies LENSAR Electromed Pro-Dex Pheton Sight Sciences (NASDAQ:SGHT) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends. Which has better earnings and valuation, SGHT or DXR? Daxor has lower revenue, but higher earnings than Sight Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSight Sciences$79.87M2.26-$51.51M-$0.98-3.56Daxor$2.13M23.02N/AN/AN/A Do insiders and institutionals have more ownership in SGHT or DXR? 55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 30.9% of Sight Sciences shares are held by insiders. Comparatively, 59.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is SGHT or DXR more profitable? Daxor has a net margin of 0.00% compared to Sight Sciences' net margin of -63.24%. Daxor's return on equity of 0.00% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Sight Sciences-63.24% -54.62% -34.92% Daxor N/A N/A N/A Does the media favor SGHT or DXR? In the previous week, Sight Sciences had 1 more articles in the media than Daxor. MarketBeat recorded 3 mentions for Sight Sciences and 2 mentions for Daxor. Daxor's average media sentiment score of 0.94 beat Sight Sciences' score of 0.46 indicating that Daxor is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sight Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Daxor 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, SGHT or DXR? Sight Sciences has a beta of 2.47, meaning that its stock price is 147% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500. Do analysts prefer SGHT or DXR? Sight Sciences presently has a consensus price target of $3.93, suggesting a potential upside of 12.70%. Daxor has a consensus price target of $25.00, suggesting a potential upside of 146.55%. Given Daxor's stronger consensus rating and higher possible upside, analysts clearly believe Daxor is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryDaxor beats Sight Sciences on 8 of the 13 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.37M$3.78B$5.70B$9.50BDividend YieldN/A1.34%4.69%4.01%P/E RatioN/A32.7428.1020.06Price / Sales23.02123.93428.7189.10Price / CashN/A21.9036.2258.56Price / BookN/A4.408.665.87Net IncomeN/A$189.47M$3.25B$258.55M7 Day Performance12.67%2.10%4.22%3.73%1 Month Performance5.30%-4.24%10.51%11.75%1 Year Performance12.67%-2.92%34.40%18.02% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxor3.9714 of 5 stars$10.14+1.4%$25.00+146.5%+12.0%$48.37M$2.13M0.0037SGHTSight Sciences1.5411 of 5 stars$3.57+4.1%$3.93+10.2%-56.5%$177.32M$79.87M-3.64210Upcoming EarningsTLSITriSalus Life Sciences2.841 of 5 stars$4.50-1.5%$10.75+138.9%-20.1%$172.92M$29.43M-4.02106News CoverageGap DownINGNInogen4.2482 of 5 stars$6.34+0.8%$11.00+73.5%-29.9%$169.12M$335.70M-5.511,030PROFProfound Medical2.6593 of 5 stars$5.87+5.8%$11.00+87.4%-47.9%$166.79M$11.86M-4.81150News CoverageKRMDKORU Medical Systems2.8847 of 5 stars$3.43-0.9%$4.50+31.2%+39.2%$159.65M$33.65M-31.1880Positive NewsBSGMBiosig Technologies1.9472 of 5 stars$6.10+5.9%$10.00+63.9%+964.4%$157.22M$40K0.0050Gap UpHigh Trading VolumeLNSRLENSAR1.2718 of 5 stars$13.07-1.9%$15.00+14.8%+143.0%$157.07M$57.07M-2.69110Positive NewsELMDElectromed1.2781 of 5 stars$18.69+3.1%$33.50+79.2%+26.9%$156.73M$61.44M24.92160News CoverageAnalyst ForecastAnalyst RevisionPDEXPro-Dex2.4778 of 5 stars$47.67+2.2%$56.00+17.5%+159.1%$152.16M$53.84M17.03140PTHLPhetonN/A$22.50-0.5%N/AN/A$148.82M$450K0.0011Positive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies Sight Sciences Alternatives TriSalus Life Sciences Alternatives Inogen Alternatives Profound Medical Alternatives KORU Medical Systems Alternatives Biosig Technologies Alternatives LENSAR Alternatives Electromed Alternatives Pro-Dex Alternatives Pheton Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXR Stock Alerts